About
Venture Partner at F-Prime focused on early-stage biotechnology investments, and founding CEO of gene and cell therapy company Skyline Therapeutics. She was previously a founding member and Head of Operations of Novartis' R&D Center in China, holds a PhD from MIT in GPCR signaling, and an MBA from MIT Sloan.
Invests in
Biotech
Colleagues at F-Prime Capital
Abby Wagner
Senior Accountant at F-Prime Capital Partners
Abdul Abdirahman
Principal at F-Prime Capital Partners
Alex Pasteur
Partner at F-Prime Capital Partners
Alex Wong
Associate at F-Prime Capital Partners
Allan Galper
Vice President & Associate General Counsel at F-Prime Capital Partners
Allison MacLeod
Venture Partner at F-Prime Capital Partners
Andrew Bognanni
Director of Finance at F-Prime Capital Partners
Bala Varadhan
Principal at F-Prime Capital Partners
Frequently asked questions
- Who is Amber Cai?
- Venture Partner at F-Prime focused on early-stage biotechnology investments, and founding CEO of gene and cell therapy company Skyline Therapeutics. She was previously a founding member and Head of Operations of Novartis' R&D Center in China, holds a PhD from MIT in GPCR signaling, and an MBA from MIT Sloan.
- Where does Amber Cai work?
- Amber Cai is Venture Partner at F-Prime Capital.
- What does Amber Cai invest in?
- Amber Cai invests in Biotech.